Equine CYP2B6: genomic annotation, heterologous expression and its role in the metabolism of ketamine

被引：0
|
作者：
Schmitz, A. [1 ]
Peters, L. [2 ]
Demmel, S. [2 ]
Haase, B. [3 ]
Buters, J. [4 ]
Thormann, W. [5 ]
Leeb, T. [3 ]
Mevissen, M. [2 ]
机构：
[1] Univ Bern, Bern, Switzerland
[2] Uni Bern, Vetsuisse Fac, Div Vet Pharmacol & Toxicol, Bern, Switzerland
[3] Uni Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland
[4] Tech Univ Munich, Helmholtz Zentrum Munchen, ZAUM Ctr Allergy & Environm, Munich, Germany
[5] Uni Bern, Inst Infect Dis, Clin Pharmacol Lab, Bern, Switzerland
来源：
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [1] CYP2B6*6 or Not CYP2B6*6-That Remains a Question for Precision Medicine and Ketamine!
    Cook-Sather, Scott D.
    Adamson, Peter C.
    Li, Jin
    Hakonarson, Hakon
    ANESTHESIOLOGY, 2016, 125 (06) : 1085 - 1087
  • [2] The role of CYP2B6 in human xenobiotic metabolism
    Ekins, S
    Wrighton, SA
    DRUG METABOLISM REVIEWS, 1999, 31 (03) : 719 - 754
  • [3] Role of CYP2B6 in stereoselective human methadone metabolism
    Totah, Rheem A.
    Sheffels, Pamela
    Roberts, Toni
    Whittington, Dale
    Thummel, Kenneth
    Kharasch, Evan D.
    ANESTHESIOLOGY, 2008, 108 (03) : 363 - 374
  • [4] Determination of CYP2B6 protein expression levels in human liver microsomes and its potential role in methadone metabolism
    Totah, R
    Roberts, T
    Sheffels, P
    Wittington, D
    Xu, Y
    Thummel, K
    Kharasch, E
    DRUG METABOLISM REVIEWS, 2004, 36 : 73 - 73
  • [5] ROLE OF CYP2B6 POLYMORPHISM IN THE METABOLISM AND PHARMACOKINETICS OF METHADONE ENANTIOMERS
    Somogyi, A. A.
    Coller, J. K.
    Foster, D. B. F.
    Li, Y.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 32 - 32
  • [6] CYP2B6*6 ALLELE ALTERS KETAMINE'S PHARMACOKINETICS IN CHRONIC PAIN PATIENTS AND METABOLISM IN VITRO
    Li, Yibai
    Coller, Janet K.
    Hutchinson, Mark R.
    Klein, Kathrin
    Zanger, Ulrich M.
    Currow, David
    Slon, Barry
    Jackson, Kate
    Somogyi, Andrew A.
    DRUG METABOLISM REVIEWS, 2014, 45 : 26 - 26
  • [7] Differences in Methadone Metabolism by CYP2B6 Variants
    Gadel, Sarah
    Friedel, Christina
    Kharasch, Evan D.
    DRUG METABOLISM AND DISPOSITION, 2015, 43 (07) : 994 - 1001
  • [8] The effects of CYP2B6 inactivators on the metabolism of ciprofol
    Lu, Ming
    Zhang, Xiaorui
    Li, Wenli
    Li, Xiangchen
    Li, Shan
    Yin, Xiaoyu
    Zhang, Zhiqing
    PLOS ONE, 2024, 19 (07):
  • [9] Effects of the CYP2B6*6 Allele on Catalytic Properties and Inhibition of CYP2B6 In Vitro: Implication for the Mechanism of Reduced Efavirenz Metabolism and Other CYP2B6 Substrates In Vivo
    Xu, Cong
    Ogburn, Evan T.
    Guo, Yingying
    Desta, Zeruesenay
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (04) : 717 - 725
  • [10] KETAMINE AND KETAMINE METABOLITES AS NOVEL ESTROGEN RECEPTOR LIGANDS: INDUCTION OF CYP2A6, CYP2B6 AND AMPA RECEPTOR -GENOMIC LINKS TO SEX-DIFFERENCES IN KETAMINE RESPONSE.
    Ho, M. -F.
    Correia, M. Miranda de Araujo
    Ingle, J. N.
    Wang, L.
    Kaufmann, S. H.
    Weinshilboum, R. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 : S5 - S5
12345